|
|
Previous Article | Table of Contents | Next Article 
Molecular characterization of 16p deletions associated with inversion 16
defines the critical fusion for leukemogenesis
P Marlton, DF Claxton, P Liu, EH Estey, M Beran, M LeBeau, JR Testa, FS Collins, JD Rowley and MJ Siciliano
Department of Hematology, University of Texas M.D. Anderson Cancer Center,
Houston 77030.
The inversion of chromosome 16 [inv(16)] in acute myeloid leukemia (AML) is
associated with a p-arm deletion in a subset of patients. The inversion
results in two fusion genes: 5'-CBFB/MYH11-3' on 16p and 5'- MYH11/CBFB-3'
on 16q. We have studied cells from 42 patients with inv(16) (38 patients)
or t(16;16) (four patients) to define the frequency and characteristics of
the deletion further. Using fluorescence in situ hybridization (FISH) with
probes from cosmids, cosmid contigs, and yeast artificial chromosomes
(YACs), we found that six patients with inv(16) had a deletion of between
150 and 350 kb centromeric to the p-arm inversion breakpoint cluster region
(p-ibc). This region was shown to contain the 5' portion of the myosin
heavy chain (MYH11) gene. YACs containing the p-ibc, which had been useful
as FISH probes in the diagnosis of inv(16), detected the inversion in
deletion as well as nondeletion patient cells. Thus, the deleted region
identified in patients is entirely contained within the human genomic
content of the YACs. Southern blot experiments using probes flanking the
p-ibc indicated that the deletion removes segments within 10 kb centromeric
of the p-ibc. Reverse transcription-polymerase chain reaction (RT-PCR)
using primers from the 5' region of CBFB and the 3' region of MYH11 (distal
to the p-ibc) produced the 5'-CBFB/MYH11-3' chimeric transcript in
inv(16)/del patients. These data confirm that the 5'-CBFB/MYH11-3' chimeric
transcript, rather than the reciprocal 5'- MYH11/CBFB-3', is the critical
product for chromosome 16-related leukemogenesis.
Volume 85,
Issue 3,
pp. 772-779,
02/01/1995
Copyright © 1995 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. J. P. Huntly, A. Bench, and A. R. Green
Double jeopardy from a single translocation: deletions of the derivative chromosome 9 in chronic myeloid leukemia
Blood,
August 15, 2003;
102(4):
1160 - 1168.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. P. Huntly, A. J. Bench, E. Delabesse, A. G. Reid, J. Li, M. A. Scott, L. Campbell, J. Byrne, E. Pinto, A. Brizard, et al.
Derivative chromosome 9 deletions in chronic myeloid leukemia: poor prognosis is not associated with loss of ABL-BCR expression, elevated BCR-ABL levels, or karyotypic instability
Blood,
May 29, 2002;
99(12):
4547 - 4553.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. G. Thomas, J. M. Olson, S. J. Tapscott, and L. P. Zhao
An Efficient and Robust Statistical Modeling Approach to Discover Differentially Expressed Genes Using Genomic Expression Profiles
Genome Res.,
July 1, 2001;
11(7):
1227 - 1236.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Kolomietz, J. Al-Maghrabi, S. Brennan, J. Karaskova, S. Minkin, J. Lipton, and J. A. Squire
Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis
Blood,
June 1, 2001;
97(11):
3581 - 3588.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. van der Kolk, E. Vellenga, A. Y. van der Veen, L. Noordhoek, H. Timmer-Bosscha, G. J. Ossenkoppele, R. A. Raymakers, M. Muller, E. van den Berg, and E. G. E. de Vries
Deletion of the multidrug resistance protein MRP1 gene in acute myeloid leukemia: the impact on MRP activity
Blood,
June 1, 2000;
95(11):
3514 - 3519.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. B. Sinclair, E. P. Nacheva, M. Leversha, N. Telford, J. Chang, A. Reid, A. Bench, K. Champion, B. Huntly, and A. R. Green
Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia
Blood,
February 1, 2000;
95(3):
738 - 743.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Li and J. Gergen
Differential interactions between Brother proteins and Runt domain proteins in the Drosophila embryo and eye
Development,
January 8, 1999;
126(15):
3313 - 3322.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Adya, T. Stacy, N. A. Speck, and P. P. Liu
The Leukemic Protein Core Binding Factor beta (CBFbeta )-Smooth-Muscle Myosin Heavy Chain Sequesters CBFalpha 2 into Cytoskeletal Filaments and Aggregates
Mol. Cell. Biol.,
December 1, 1998;
18(12):
7432 - 7443.
[Abstract]
[Full Text]
|
 |
|
|
|